An integrative functional genomics approach for discovering biomarkers in Schizophrenia

Briefings in Functional Genomics

Volumn 10, Issue 6, 2011, Pages 387-399

  Vawter, Marquis P ^a   Mamdani, Firoza ^a   Macciardi, Fabio ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cis regulatory SNPs; Expression quantitative trait loci; Gene expression; GWAS; Lymphoblastoid cell lines

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; NEU DIFFERENTIATION FACTOR; SHORT HAIRPIN RNA;

ALLELE; AUTOPSY; BIPOLAR DISORDER; BRAIN TISSUE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DNA STRUCTURE; EXON; FOLLOW UP; FUNCTIONAL GENOMICS; GABAERGIC TRANSMISSION; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE INSERTION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; LYMPHOCYTE; PHENOTYPE; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE TRAIT LOCUS; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; TRANSCRIPTION INITIATION SITE; UPREGULATION;

BIOLOGICAL MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; SCHIZOPHRENIA;

EID: 84555189458     PISSN: 20412649     EISSN: 20412657     Source Type: Journal    
DOI: 10.1093/bfgp/elr036     Document Type: Review

References (118)

1. Harris EC, Barraclough B. Excess mortality of mental disorder. BrJ Psychiatry 1998, 173: 11-53.
2. Sullivan PF. The genetics of schizophrenia. PLoSMed 2005, 2: e212.
3. Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460: 748-52.
4. Ikeda M, Aleksic B, Kinoshita Y, et al. Genome-wide association study of schizophrenia in a Japanese population. Biol Psychiatry 2011, 69: 472-8.
5. Freedman R, Ross R, Leonard S, et al. Early biomarkers of psychosis. Dialogues ClinNeurosci 2005, 7: 17-29.
6. Stober G, Ben-Shachar D, Cardon M, et al. Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers. World J Biol Psychiatry 2009, 10: 127-55.
7. Cheng TM, Lu YE, Guest PC, et al. Identification of targeted analyte clusters for studies of schizophrenia. Mol Cell Proteomics 2010, 9: 510-22.
8. Glatt SJ, Everall IP, Kremen WS, et al. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. ProcNatl Acad SciUSA 2005, 102: 15533-8.
9. Herberth M, Schwarz E, Bahn S. Problems and promise of immunological factors as biomarkers for schizophrenia. Biomark Med 2008, 2: 385-95.
10. Kanazawa T, Chana G, Glatt SJ, et al. The utility of SELENBP1 gene expression as a biomarker for major psychotic disorders: replication in schizophrenia and extension to bipolar disorder with psychosis. AmJ Med Genet B Neuropsychiatr Genet 2008, 147: 686-9.
11. Kuzman MR, Medved V, Terzic J, et al. Genome-wide expression analysis of peripheral blood identifies candidate biomarkers for schizophrenia. J Psychiatr Res 2009, 43: 1073-7.
12. Niculescu AB, Lulow LL, Ogden CA, et al. PhenoChipping of psychotic disorders: a novel approach for deconstructing and quantitating psychiatric phenotypes. Am J Med Genet B Neuropsychiatr Genet 2006, 141: 653-62.
13. Novikova SI, He F, Cutrufello NJ, et al. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOFPSD-MS analysis. Neurobiol Dis 2006, 23: 61-76.
14. Schwarz E, Izmailov R, Spain M, et al. Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia. Biomark Insights 2010, 5: 39-47.
15. Strous RD, Shoenfeld Y. The mosaic of schizophrenia: Has the time arrived to monitor the illness with biomarkers? Clin Biochem 2008, 41: 353-4.
16. Tsuang MT, Nossova N, Yager T, et al. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005, 133: 1-5.
17. van den Oord EJ, Adkins DE, McClay J, et al. A systematic method for estimating individual responses to treatment with antipsychotics in CATIE. Schizophr Res 2009, 107: 13-21.
18. Webb BT, Sullivan PF, Skelly T, et al. Model-based gene selection shows engrailed 1 is associated with antipsychotic response. Pharmacogenet Genom 2008, 18: 751-9.
19. Yao Y, Schroder J, Karlsson H. Verification of proposed peripheral biomarkers in mononuclear cells of individuals with schizophrenia. J Psychiatr Res 2008, 42: 639-43.
20. Middleton FA, Pato CN, Gentile KL, et al. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am J Med Genet B Neuropsychiatr Genet 2005, 136: 12-25.
21. Craddock RM, Lockstone HE, Rider DA, et al. Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms. PLoS One 2007, 2: e692.
22. Vawter MP, Ferran E, Galke B, et al. Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr Res 2004, 67: 41-52.
23. Vawter MP, Atz M, Rollins B, etal. Genome scans and gene expression microarrays converge to identify gene regulatory loci relevant in schizophrenia. BiolPsychiatry 2006, 59: 6S-7S.
24. Vawter MP, Harvey PD, DeLisi LE. Dysregulation of X-linked gene expression in Klinefelter's syndrome and association with verbal cognition. Neuropsychopharmacology 2006, 31: S258-9.
25. Martin MV, Rollins B, Sequeira PA, et al. Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation. BMC Med Genomics 2009, 2: 62.
26. Lavebratt C, Sjoholm LK, Soronen P, et al. CRY2 Is Associated with Depression. PLoS One 2010, 5: e9407.
27. Potkin SG, Macciardi F, Guffanti G, et al. Identifying gene regulatory networks in schizophrenia. Neuroimage 2010, 53: 839-47.
28. Rollins B, Martin MV, Morgan L, et al. Analysis of whole genome biomarker expression in blood and brain. Am J Med Genet BNeuropsychiatr Genet 2010, 153B: 919-36.
29. Fraser HB, Xie X. Common polymorphic transcript variation in human disease. Genome Res 2009, 19: 567-75.
30. Sequeira PA, Martin MV, Vawter MP. The first decade and beyond of transcriptional profiling in schizophrenia. Neurobiol Dis 2011 [Epub ahead of print, doi: 10.1016/ j.nbd.2011.03.001].
31. Arion D, Unger T, Lewis DA, et al. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry 2007, 62: 711-21.
32. Kim S, Choi KH, Baykiz AF, et al. Suicide candidate genes associated with bipolar disorder and schizophrenia: an exploratory gene expression profiling analysis of post-mortem prefrontal cortex. BMCGenomics 2007, 8: 413.
33. Saetre P, Emilsson L, Axelsson E, etal. Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry 2007, 7: 46.
34. Shao L, Vawter MP. Shared gene expression alterations in schizophrenia and bipolar disorder. Biol Psychiatry 2008, 64: 89-97.
35. Dracheva S, Elhakem SL, McGurk SR, et al. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J Neurosci Res 2004, 76: 581-92.
36. Duncan CE, Webster MJ, Rothmond DA, et al. Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia. J Psychiatric Res 2010, 44: 673-81.
37. Hakak Y, Walker JR, Li C, et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 2001, 98: 4746-51.
38. Hashimoto T, Arion D, Unger T, et al. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 2008, 13: 147-61.
39. Mirnics K, Middleton FA, Marquez A, etal. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000, 28: 53-67.
40. Straub RE, Lipska BK, Egan MF, et al. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry 2007, 12: 854-69.
41. Liew CC, Ma J, Tang HC, et al. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 2006, 147: 126-32.
42. Sullivan PF, Fan C, Perou CM. Evaluating the comparability of gene expression in blood and brain. AmJMed Genet B Neuropsychiatr Genet 2006, 141B: 261-8.
43. Atz M, Walsh D, Cartagena P, et al. Methodological considerations for gene expression profiling of human brain. J Neurosci Methods 2007, 163: 295-309.
44. Zhang D, Cheng L, Badner JA, et al. Genetic control of individual differences in gene-specific methylation in human brain. Am J Hum Genet 2010, 86: 411-9.
45. Yao Y, Schroder J, Karlsson H. Verification of proposed peripheral biomarkers in mononuclear cells of individuals with schizophrenia. J Psychiatric Res 2008, 42: 639-43.
46. Bousman CA, Chana G, Glatt SJ, etal. Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood. Am J Med Genet B Neuropsychiatr Genet 2010, 153B: 1336-41.
47. Takahashi M, Hayashi H, Watanabe Y, et al. Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures. Schizophrenia Res 2010, 119: 210-8.
48. Lai CY, Yu SL, Hsieh MH, et al. MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PloS one 2011, 6: e21635.
49. Beveridge NJ, Gardiner E, Carroll AP, et al. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry 2010, 15: 1176-89.
50. Gardiner E, Beveridge NJ, Wu JQ, et al. Imprinted DLK1-DIO3 region of 14q32 defines a schizophreniaassociated miRNA signature in peripheral blood mononuclear cells. Mol Psychiatry 2011 [Epub ahead of print, doi: 10.1038/mp.2011.78].
51. Mitkus SN, Hyde TM, Vakkalanka R, et al. Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Schizophrenia Res 2008, 98: 129-38.
52. Richards AL, Jones L, Moskvina V, et al. Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain. Mol Psychiatry 2011 [Epub ahead of print, doi: 10.1038/mp.2011.11].
53. Williams HJ, Norton N, Dwyer S, et al. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry 2011, 16: 429-41.
54. Steinberg S, Mors O, Borglum AD, et al. Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry 2011, 16: 59-66.
55. Riley B, Thiselton D, Maher BS, et al. Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample. Mol Psychiatry 2010, 15: 29-37.
56. O'Donovan MC, Norton N, Williams H, et al. Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Mol Psychiatry 2009, 14: 30-6.
57. Buonocore F, Hill MJ, Campbell CD, et al. Effects of cis-regulatory variation differ across regions of the adult human brain. Hum Mol Genet 2010, 19: 4490-6.
58. Nicolae DL, Gamazon E, Zhang W, et al. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet 2010, 6: e1000888.
59. Montgomery SB, Dermitzakis ET. From expression QTLs to personalized transcriptomics. Nat Rev Genet 2011, 12: 277-82.
60. Ruderfer DM, Kirov G, Chambert K, et al. A family-based study of common polygenic variation and risk of schizophrenia. Mol Psychiatry 2011, 16: 887-8.
61. Potkin SG, Turner JA, Guffanti G, et al. A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. Schizophr Bull 2009, 35: 96-108.
62. Huang RS, Duan S, Kistner EO, et al. Identification of genetic variants and gene expression relationships associated with pharmacogenes in humans. Pharmacogenet Genomics 2008, 18: 545-9.
63. Gamazon ER, Zhang W, Konkashbaev A, et al. SCAN: SNP and copy number annotation. Bioinformatics 2010, 26: 259-62.
64. Vawter MP, Atz ME, Rollins BL, et al. Genome scans and gene expression microarrays converge to identify gene regulatory loci relevant in schizophrenia. Hum Genet 2006, 119: 558-70.
65. Dixon AL, Liang L, Moffatt MF, et al. A genome-wide association study of global gene expression. Nat Genet 2007, 39: 1202-7.
66. Kaneko N, Muratake T, Kuwabara H, et al. Autosomal linkage analysis of a Japanese single multiplex schizophrenia pedigree reveals two candidate loci on chromosomes 4q and 3q. AmJMed Genet BNeuropsychiatrGenet 2007, 144: 735-42.
67. Kwan T, Benovoy D, Dias C, et al. Heritability of alternative splicing in the human genome. Genome Res 2007, 17: 1210-8.
68. Graham RR, Kyogoku C, Sigurdsson S, et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci USA 2007, 104: 6758-63.
69. Potkin SG, Turner JA, Guffanti G, et al. Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations. Cogn Neuropsychiatry 2009, 14: 391-418.
70. Potkin SG, Turner JA, Fallon JA, et al. Gene discovery through imaging genetics: identification of two novel genes associated with schizophrenia. Mol Psychiatry 2009, 14: 416-28.
71. Lucas B, Grigo K, Erdmann S, et al. HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma. Oncogene 2005, 24: 6418-31.
72. Ryan MM, Lockstone HE, Huffaker SJ, et al. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 2006, 11: 965-78.
73. Sibille E, Arango V, Galfalvy HC, et al. Gene expression profiling of depression and suicide in human prefrontal cortex. Neuropsychopharmacology 2004, 29: 351-61.
74. Davidson ME, Kerepesi LA, Soto A, et al. D-Serine exposure resulted in gene expression changes implicated in neurodegenerative disorders and neuronal dysfunction in male Fischer 344 rats. Arch Toxicol 2009, 83: 747-62.
75. Allen NC, Bagade S, McQueen MB, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008, 40: 827-34.
76. Duan S, Huang RS, Zhang W, etal. Genetic architecture of transcript-level variation in humans. Am J Hum Genet 2008, 82: 1101-13.
77. Stranger BE, Nica AC, Forrest MS, et al. Population genomics of human gene expression. Nat Genet 2007, 39: 1217-24.
78. Bemmo A, Benovoy D, Kwan T, et al. Gene expression and isoform variation analysis using Affymetrix Exon Arrays. BMC Genomics 2008, 9: 529.
79. Benovoy D, Kwan T, Majewski J. Effect of polymorphisms within probe-target sequences on olignonucleotide microarray experiments. Nucleic Acids Res 2008, 36: 4417-23.
80. Heinzen EL, Ge D, Cronin KD, etal. Tissue-specific genetic control of splicing: implications for the study of complex traits. PLoS Biol 2008, 6: e1.
81. Kwan T, Benovoy D, Dias C, et al. Genome-wide analysis of transcript isoform variation in humans. Nat Genet 2008, 40: 225-31.
82. Sequeira A, Meng F, Rollins B, et al. Coding SNPs included in exon arrays for the study of psychiatric disorders. Mol Psychiatry 2008, 13: 363-5.
83. Duan S, Huang RS, Zhang W, et al. Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell lines. Pharmacogenomics 2009, 10: 549-63.
84. Gamazon ER, Zhang W, Dolan ME, et al. Comprehensive survey of SNPs in the Affymetrix exon array using the 1000 Genomes dataset. PLoS One 2010, 5: e9366.
85. Pradervand S, Paillusson A, Thomas J, et al. Affymetrix Whole-Transcript Human Gene 1.0 ST array is highly concordant with standard 3' expression arrays. BioTechniques 2008, 44: 759-62.
86. Agarwal A, Koppstein D, Rozowsky J, et al. Comparison and calibration of transcriptome data from RNA-Seq and tiling arrays. BMC Genomics 2010, 11: 383.
87. Bradford JR, Hey Y, Yates T, et al. A comparison of massively parallel nucleotide sequencing with oligonucleotide microarrays for global transcription profiling. BMC Genomics 2010, 11: 282.
88. Liu S, Lin L, Jiang P, et al. A comparison of RNA-Seq and high-density exon array for detecting differential gene expression between closely related species. Nucleic Acids Res 2011, 39: 578-88.
89. Richard H, Schulz MH, Sultan M, et al. Prediction of alternative isoforms from exon expression levels in RNA-Seq experiments. Nucleic Acids Res 2010, 38: e112.
90. Xu W, Seok J, Mindrinos MN, et al. Human transcriptome array for high-throughput clinical studies. ProcNatl Acad Sci USA 2011, 108: 3707-12.
91. Irizarry RA, Bolstad BM, Collin F, et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003, 31: e15.
92. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4: 249-64.
93. Duan S, Zhang W, Bleibel WK, et al. SNPinProbe_1.0: a database for filtering out probes in the Affymetrix GeneChip human exon 1.0 ST array potentially affected by SNPs. Bioinformation 2008, 2: 469-70.
94. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. AmJHum Genet 2007, 81: 559-75.
95. Norris AW, Kahn CR. Analysis of gene expression in pathophysiological states: balancing false discovery and false negative rates. Proc Natl Acad Sci USA 2006, 103: 649-53.
96. Lee HK, Braynen W, Keshav K, et al. ErmineJ: tool for functional analysis of gene expression data sets. BMCBioinformatics 2005, 6: 269.
97. Dennis G Jr, Sherman BT, Hosack DA, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003, 4: 3.
98. O'Dushlaine C, Kenny E, Heron EA, et al. The SNP ratio test: pathway analysis of genome-wide association datasets. Bioinformatics 2009, 25: 2762-3.
99. Holmans P, Green EK, Pahwa JS, et al. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. AmJ Hum Genet 2009, 85: 13-24.
100. Ripke S, Sanders AR, Kendler KS, et al. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011, 43: 969-76.
101. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3: RESEARCH0034.
102. Tunbridge EM, Eastwood SL, Harrison PJ. Changed relative to what? Housekeeping genes and normalization strategies in human brain gene expression studies. Biol Psychiatry 2011, 69: 173-9.
103. Alonso-Perez E, Suarez-Gestal M, Calaza M, et al. Cis-regulation of IRF5 expression is unable to fully account for Systemic Lupus Erythematosus association: analysis from multiple experiments with lymphoblastoid cell lines. Arthritis ResTher 2011, 13: R80.
104. Ruan J, Zhang W. Identifying network communities with a high resolution. Phys Rev E StatNonlin Soft Matter Phys 2008, 77: 016104.
105. Ruan J, Dean AK, Zhang W. A general co-expression network-based approach to gene expression analysis: comparison and applications. BMC Syst Biol 2010, 4: 8.
106. Scardoni G, Petterlini M, Laudanna C. Analyzing biological network parameters with CentiScaPe. Bioinformatics 2009, 25: 2857-9.
107. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13: 2498-504.
108. Assenov Y, Ramirez F, Schelhorn SE, et al. Computing topological parameters of biological networks. Bioinformatics 2008, 24: 282-4.
109. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008, 9: 559.
110. Saris CG, Horvath S, van Vught PW, et al. Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients. BMC Genomics 2009, 10: 405.
111. Mahato RI, Cheng K, Guntaka RV. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA. Expert OpinDrug Deliv 2005, 2: 3-28.
112. Milhavet O, Gary DS, Mattson MP. RNA interference in biology and medicine. Pharmacol Rev 2003, 55: 629-48.
113. Scherer LJ, Rossi JJ. Approaches for the sequence-specific knockdown of mRNA. Nat Biotechnol 2003, 21: 1457-65.
114. Scherr M, Morgan MA, Eder M. Gene silencing mediated by small interfering RNAs in mammalian cells. Curr Med Chem 2003, 10: 245-56.
115. Li JZ, Meng F, Tsavaler L, et al. Sample matching by inferred agonal stress in gene expression analyses of the brain. BMC Genomics 2007, 8: 336.
116. Li JZ, Vawter MP, Walsh DM, et al. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. HumMol Genet 2004, 13: 609-16.
117. Tomita H, Vawter MP, Walsh DM, et al. Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry 2004, 55: 346-52.
118. Atz ME, Rollins B, Vawter MP. NCAM1 association study of bipolar disorder and schizophrenia: polymorphisms and alternatively spliced isoforms lead to similarities and differences. Psychiatric Genetics 2007, 17: 55-67.